Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Zhiying Yang"'
Autor:
Zhiming Zhao, Xiaomo Li, Fei Wang, Yong Xu, Si Liu, Quanli Han, Zhiying Yang, Weiwei Huang, Zhuzeng Yin, Qu Liu, Haidong Tan, Tonghui Ma, Shuang Si, Jia Huang, Hongling Yuan, Wei Li, Rong Liu
Publikováno v:
Cancer Medicine.
Autor:
Wenying Zhou, Zhiying Yang, Haidong Tan, Jia Huang, Shuang Si, Li Xu, Xiaolei Liu, Yongliang Sun, Liguo Liu
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 11, Pp 3668-3679 (2020)
Cancer Medicine, Vol 9, Iss 11, Pp 3668-3679 (2020)
Although guidelines recommend extended surgical resection, radical resection and lymphadenectomy for patients with tumor stage (T)1b gallbladder cancer, these procedures are substantially underutilized. This population‐based, retrospective cohort s
Autor:
Yulong He, Haiyong Zhang, Xing Xiao, Jun Ouyang, Tailai An, Wang Wu, Changhua Zhang, Zhiying Yang, Yawei Zhang, Bo Li, Huafu Li, Chunming Wang
Publikováno v:
Journal of Cancer
Gastric cancer (GC) is the third leading cause of cancer deaths worldwide. Conventional chemotherapy has been proven useful to only a portion of the patients. Previous developed targeted drugs are more effective and tolerable than conventional drugs.
Publikováno v:
Cancer Management and Research
Xiaolei Liu, Zihuan Zhang, Jia Huang, Haidong Tan, Zhiying Yang Department of Hepatobiliary Surgery, China-Japan Friendship Hospital, Beijing, Peopleâs Republic of ChinaCorrespondence: Zhiying YangDepartment of Hepatobiliary Surgery, China-Japan
Autor:
Yu Feng, Liguo Liu, Jing Li, Jia Huang, Jenny Xie, Laurence Menard, Yanfen Shi, Xiaohong Zhao, Shan Xie, Wenjuan Zang, Haidong Tan, Zhiying Yang, Ling Ni
Publikováno v:
Oncology Reports
Hepatocellular carcinoma (HCC) is an immunogenic malignancy, which exhibits low responsiveness to programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) antibodies. Therefore, the identification of novel immunotherapeutic targets to
Autor:
Xueying Huang, Zhiying Yang, Jinning Zhang, Ruojiao Wang, Jiahui Fan, Heng Zhang, Rong Xu, Xia Li, Siying Yu, Linna Long, He Huang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2022)
Background: The number of publications on SMAD7 in the field of oncology is increasing rapidly with an upward tendency. In most cases, the mechanisms of carcinogenesis usually relate to disorders of signaling activity. Considering the crucial role of
Autor:
Jia Huang, Zai Wang, Wenying Zhou, Yongliang Sun, Shuang Si, Zhiying Yang, Shan Wu, Huizhuo Sun, Haidong Tan, Xiaolei Liu, Liguo Liu, Li Xu
Publikováno v:
Molecular Medicine Reports
Serum interleukin (IL)‑17A level is associated with higher microvessel density and poor prognosis in liver cancer. However, the specific mechanism underlying the role of IL‑17A in liver cancer remains controversial. In the present study, the effe
Autor:
Jia Huang, Haidong Tan, Shan Xie, Shanjuan Hong, Qin Qiao, Zhiying Yang, Chen Dong, Wenjuan Zang, Ling Ni
Publikováno v:
Cancer Immunology, Immunotherapy. 67:1685-1694
Colorectal carcinoma (CRC) is one of the most common malignancies in the world. PD-1/PD-L1 inhibitors have benefited cancer patients with multiple tumor types. However, their efficacy for CRC is low and this treatment in melanoma patients results in
Publikováno v:
Oncology Letters
Multiple endocrine neoplasia type 1 (MEN1) is associated with a heterozygous inherited mutation of the menin 1 (MEN1) gene; however, the molecular pathogenesis remains to be fully elucidated. In the present study, whole exome sequencing was performed
Autor:
Qianjin Liao, Heran Wang, Yujuan Zhou, Baihua Zhang, Linda Oyang, Xia Luo, Zhiying Yang, Jianping Liang, Xiao Yan Chen, Longzheng Xia
Publikováno v:
Journal of Cancer
Objective: p21-activated kinases (PAKs) are serine/threonine protein kinases. PAK1 and epithelial-mesenchymal transition (EMT) are key therapeutic targets in cancer. The clinical significance of PAK1 and its potential association with EMT phenotype i